Coronary artery disease intervention considerations in elderly patients

46 151 0
Coronary artery disease intervention considerations in elderly patients

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

Thông tin tài liệu

Coronary Artery Disease Intervention Considerations in Elderly Patients A/Prof Phạm Mạnh Hùng, MD.FACC.FESC Director Cardiac Cath.Lab – Vietnam Heart Institute Secretary General – Vietnam Heart Association PCI Patient Case • 83 year old male, small NSTEMI, moderate LMCA, vessel disease, AAA, moderate MR, chronic atrial fibrillation, diabetes • How to proceed? • • • • (CAD) Interventionalist – PCI; (AAA) Stent Graft? Surgeon – CABG General Cardiologist – medication Patient - Are they even in the decision making process?? Cor Angio Treatment Methods Selection • Medical ? • Surgery? • Intervention? To intervene or not??? Coronary disease AAA Complex Trade-offs • Clinical Questions: • • • • • • • • • • Optimal medical therapy?, PCI ?, DES/BMS?, CABG? 1, 2, or vessel, LMCA involvement and % stenosis? Anatomy suitable – SYNTAX Score? Severity of ischemia? Diabetic? LV function and concomitant valvular disease? Other co-morbidities? Prior PCI or CABG? Potential future elective non-cardiac surgery? Patient ability for maintaining clopidogrel adherence? Goals of Coronary Revascularization • • • • Positively impact longevity/mortality Improvement in health status/symptoms Ability to influence either is not equal for all clinical scenarios Longevity gains limited to selective patient scenarios - PCI vs CABG Effects of Aging on Coronary Arteries  Dilation  Tortuosity  Medial calcification  Impaired endothelial function Effects of Aging on Ventricular Function   diastolic filling,  LVEDP   afterload (arterial stiffening)   myocardial thickness  Filling more dependent on atrial kick  Prolonged time of relaxation  Lower EF  Lower cardiac output Paclitaxel-Eluting Stent Outcomes in the Elderly Circ Cardiovasc Intervent 2009;2:178-187 TIME: Randomized trial of Invasive vs Medical Therapy Age > 75 yrs, chronic angina Lancet 2001; 358: 951-957 FRISC II Benefit of an Invasive Strategy in NSTEACS: Greatest in patients > 65 years of age Death or MI at Months Age

Ngày đăng: 30/08/2015, 11:43

Từ khóa liên quan

Tài liệu cùng người dùng

Tài liệu liên quan